GlassScriptPhysician profile
Leonard Treanor
NPI 1487823506
$28,615.55
in general payments reported to CMS, 2019-2025
73 companies · $5,122 in 2025
The $5,122 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,528 · 2020: $1,170 · 2021: $2,849 · 2022: $2,974 · 2023: $5,790 · 2024: $8,182 · 2025: $5,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $7,274 · Travel and Lodging: $911 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,800.00 |
| Food and Beverage | $7,273.58 |
| Travel and Lodging | $911.47 |
| Education | $109.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14,685.86 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,116.11 | 2019-2025 | Ubrelvy |
| Amgen INC. | $1,115.88 | 2019-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $963.60 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Organogenesis INC. | $957.53 | 2019-2025 | Puraply, Apligraf, Puraply Wound Matrix |
| Impulse Dynamics (USA) INC. | $750.45 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $582.27 | 2019-2025 | Spravato |
| Horizon Therapeutics Plc | $543.18 | 2019-2023 | Krystexxa |
| Amarin Pharma, INC. | $528.88 | 2019-2022 | |
| Allergan, INC. | $424.55 | 2019-2020 | |
| Abbott Laboratories | $361.97 | 2021-2023 | Merlin@Home |
| Glaxosmithkline, LLC. | $344.08 | 2019-2024 | Trelegy Ellipta |
| Pfizer INC. | $328.65 | 2019-2025 | |
| Abiomed | $326.69 | 2022-2024 | Impella |
| Teva Pharmaceuticals USA, INC. | $287.75 | 2025 | Austedo Xr |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $282.00 | 2023-2025 | Rexulti |
| Stryker Corporation | $273.89 | 2019-2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $231.74 | 2019-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $227.47 | 2020-2022 | |
| Spr Therapeutics, INC | $209.71 | 2022 | |
| Inari Medical, INC. | $184.88 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bardy Diagnostics, INC. | $173.78 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.96 | 2022-2025 | Jardiance |
| Daiichi Sankyo INC. | $163.03 | 2019-2021 | |
| Medtronic, INC. | $158.90 | 2022 | |
| Astellas Pharma US INC | $154.83 | 2019-2023 | Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $152.97 | 2022 | |
| Axsome Therapeutics, INC. | $149.62 | 2024-2025 | Auvelity |
| Teleflex LLC | $146.48 | 2025 | Urolift |
| Jazz Pharmaceuticals INC. | $137.64 | 2019-2022 | |
| Radiometer America, INC | $128.00 | 2019 | |
| Corium, LLC | $127.82 | 2023-2024 | Azstarys |
| Bioventus LLC | $122.50 | 2021 | |
| Xeris Pharmaceuticals, INC. | $118.79 | 2023-2024 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $116.65 | 2019-2022 | |
| Boston Scientific Corporation | $112.75 | 2019-2023 | Watchman Flx |
| Smith+Nephew, INC. | $106.26 | 2019-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Kerecis Limited | $99.05 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Sunovion Pharmaceuticals INC. | $97.97 | 2019-2021 | |
| Alon Medical Technology | $97.14 | 2024 | |
| Dexcom, INC. | $91.01 | 2023-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $90.44 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $90.35 | 2022 | |
| Biogen, INC. | $81.87 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $81.38 | 2023 | Gemtesa |
| Lundbeck LLC | $78.30 | 2023-2025 | Rexulti |
| Urovant Sciences INC | $75.14 | 2022 | |
| Novartis Pharmaceuticals Corporation | $65.87 | 2019-2025 | |
| Eisai INC. | $64.88 | 2020-2021 | |
| Lilly USA, LLC | $55.83 | 2019-2025 | Mounjaro, Zepbound |
| Ironwood Pharmaceuticals, INC | $55.37 | 2021 | |
| Avanir Pharmaceuticals, INC. | $51.34 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $46.51 | 2020-2022 | |
| Ucb, INC. | $41.03 | 2024 | Nayzilam |
| Phathom Pharmaceuticals, INC. | $33.80 | 2025 | Voquezna |
| Scpharmaceuticals INC. | $31.86 | 2025 | |
| Oyster Point Pharma, INC. | $29.04 | 2023 | Tyrvaya |
| Alfasigma USA, INC. | $28.90 | 2022 | |
| Melinta Therapeutics, LLC | $26.55 | 2019 | |
| Nevro Corp. | $25.80 | 2022 | |
| Cvrx, INC. | $24.03 | 2023 | Barostim Neo System |
| Mckesson Medical-Surgical, INC. | $20.00 | 2021 | |
| Ardelyx, INC. | $19.30 | 2024 | Ibsrela |
| Globus Medical, INC. | $18.24 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $16.09 | 2019 | |
| Mallinckrodt Hospital Products INC. | $15.74 | 2020 | |
| Radius Health, INC. | $15.21 | 2020 | |
| Almatica Pharma LLC | $14.02 | 2021 | |
| Rochester Medical Corporation | $13.85 | 2021 | |
| Shire North American Group INC | $13.66 | 2019 | |
| Supernus Pharmaceuticals, INC. | $12.58 | 2022 | |
| Apria Healthcare LLC | $12.33 | 2021 | |
| Indivior INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Treanor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.